Biogen Shareholders Elect Susan Langer to Board of Directors Despite Controversy 

The company announced Monday its shareholders elected Susan Langer, current president of Souffle Therapeutics, to its board of directors, replacing her reputed romantic partner Alex Denner.  

Scroll to Top